Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.12 and traded as low as $0.0001. Arch Therapeutics shares last traded at $0.00, with a volume of 0 shares changing hands.
Arch Therapeutics Trading Down 100.0%
The business’s 50-day moving average price is $0.12.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Recommended Stories
- Five stocks we like better than Arch Therapeutics
- What is the Hang Seng index?
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
